Australia seems poised to gain access to potentially transformative treatment for weight issues: Retatrutide. The dual molecule – acting on both GLP-1 and GIP receptors – demonstrates remarkable efficacy in international studies, indicating meaningful drops in BMI. While regulatory clearance hasn